ReviewCurrent neurology and neuroscience reports2015
Medication overuse headache.
Review in Current neurology and neuroscience reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 31 citations in OpenAlex.
- Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial.The journal of headache and pain · 2016Trial
- Medication overuse headache: position statement of specialized headache centers in Brazil.Frontiers in pain research (Lausanne, Switzerland) · 2026Article
- Occupational Risk for Headache Disorders in Female Registered Nurses. A Retrospective Study.La Medicina del lavoro · 2025Article
- Concomitant anti-CGRP and immunomodulatory treatments in patients with migraine: towards integrated management strategies.Journal of neurology · 2025Article
- Evaluation of Risk Factors in Patients With Chronic Daily Headache and Medication-Overuse Headache.Brain and behavior · 2025Article
- Delayed opportunities for patient-provider communication about medication overuse headache: Mixed methods perspectives from patients and neurologists.Preventive medicine reports · 2024Article
- Association between awareness and knowledge of medication-overuse headache with medication-taking behavior among adults with migraine.PloS one · 2024Article
- Migraine management: Non-pharmacological points for patients and health care professionals.Open medicine (Warsaw, Poland) · 2022Review
- Coping and Motivation for Change-An Interview Study of the Experience From Participation in an Educational Program for Patients With Medication-Overuse Headache.Journal of patient experience · 2021Article
- Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.Cephalalgia : an international journal of headache · 2020Article
- Low-value care practice in headache: a Spanish mixed methods research study.The journal of headache and pain · 2020Article
- Medication-overuse headache: a widely recognized entity amidst ongoing debate.The journal of headache and pain · 2018Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication overuse headache (MOH) is a common and disabling headache disorder. It has a prevalence of about 1-2 % in the general population. The International Classification of Headache Disorders 3rd edition (beta version) has defined MOH as a chronic headache disorder in which the headache occurs on 15 or more days per month due to regular overuse of medication. These headaches must have been present for more than 3 months. The pathophysiology is complex and not completely known. It involves genetic and behavioural factors. There is evidence that cortical spreading depression, trigeminovascular system and neurotransmitters contribute to the pain pathway of MOH. The treatment of MOH includes patient education, stopping the offending drug(s), rescue therapy for withdrawal symptoms and preventative therapy. Relapse rates for MOH are high at 41 %. MOH can severely impact quality of life, so it is important to identify patients who are at risk of analgesic overuse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.